4.7 Review

Stem cells in retinal regeneration: past, present and future

期刊

DEVELOPMENT
卷 140, 期 12, 页码 2576-2585

出版社

COMPANY BIOLOGISTS LTD
DOI: 10.1242/dev.092270

关键词

Age-related macular degeneration; Retinitis pigmentosa; Stargardt's disease; Stem cells; Clinical trials

资金

  1. London Project to Cure Blindness
  2. Medical Research Council (MRC) UK
  3. California Institute of Regenerative Medicine (CIRM)
  4. Fight for Sight UK
  5. Lincy Foundation
  6. Macular Society
  7. National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital National Health Service (NHS) Foundation Trust
  8. University College London Institute of Ophthalmology
  9. MRC [G1000730, G0300288] Funding Source: UKRI
  10. Medical Research Council [G0300288, G1000730] Funding Source: researchfish

向作者/读者索取更多资源

Stem cell therapy for retinal disease is under way, and several clinical trials are currently recruiting. These trials use human embryonic, foetal and umbilical cord tissue-derived stem cells and bone marrow-derived stem cells to treat visual disorders such as age-related macular degeneration, Stargardt's disease and retinitis pigmentosa. Over a decade of analysing the developmental cues involved in retinal generation and stem cell biology, coupled with extensive surgical research, have yielded differing cellular approaches to tackle these retinopathies. Here, we review these various stem cell-based approaches for treating retinal diseases and discuss future directions and challenges for the field.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据